| Nov 16 |
The weight-loss frenzy is making some pharma stocks much more volatile. Will the drama continue?
|
| Nov 15 |
Powell Speaks The Truth - Market Does Not Like It, Consternation About Kennedy, Gaetz, And Hegseth
|
| Nov 15 |
Heard on the Street: RFK Jr. Is Spooking Obesity Investors Too
|
| Nov 15 |
Novo Nordisk A/S (NVO) Trembled At The End Of The Quarter
|
| Nov 15 |
RFK Jr. News Hits Global Pharma Stocks
|
| Nov 14 |
Amgen Shrugs Off Bone Density Concerns Related to Obesity Candidate
|
| Nov 14 |
Novo Nordisk to phase out human insulin pens: report
|
| Nov 14 |
Global increase in diabetes indicates more room for GLP-1 meds to grow
|
| Nov 14 |
Is AstraZeneca a Buy as It Eyes the Weight Loss Market?
|
| Nov 13 |
EU regulators quiz Novo Nordisk, Catalent rivals on $16.5 billion deal
|
